0001209191-23-058578.txt : 20231214 0001209191-23-058578.hdr.sgml : 20231214 20231214081104 ACCESSION NUMBER: 0001209191-23-058578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231214 DATE AS OF CHANGE: 20231214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Angotti Vincent J. CENTRAL INDEX KEY: 0001700225 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 231485652 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS, INC. STREET 2: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 1850 GATEWAY DRIVE STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-13 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001700225 Angotti Vincent J. C/O ACELRX PHARMACEUTICALS, INC. 1850 GATEWAY DRIVE, SUITE 175 SAN MATEO CA 94404 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-12-13 4 P 0 10000 0.7268 A 101805 D The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.7198 to $0.73 on December 13, 2023. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. /s/ Martha Adler, Attorney-In-Fact 2023-12-14